Paper Details

  1. Home
  2. Paper Details

Role of antibiotics for treatment of inflammatory bowel disease.

Author: EliasMazen, NitzanOrna, PeretzAvi, SalibaWalid

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Antibiotics have a modest effect in treating active luminal Crohn's disease, particularly in patients with colonic involvement. Rifamixin has shown promising results for active luminal CD. Antibiotics are also used for treating suppurative complications of CD.
Paper Details　
Original Abstract of the Article :
Inflammatory bowel disease is thought to be caused by an aberrant immune response to gut bacteria in a genetically susceptible host. The gut microbiota plays an important role in the pathogenesis and complications of the two main inflammatory bowel diseases: Crohn's disease (CD) and ulcerative colit...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4716021/

データ提供：米国国立医学図書館（NLM）

The Complex Role of Antibiotics in Inflammatory Bowel Disease

Inflammatory bowel disease (IBD) is a complex condition, like a desert landscape with shifting sands and unpredictable weather patterns. This study explores the role of antibiotics in the treatment of IBD, focusing on their ability to modify the gut microbiome and influence the course of disease.

Antibiotics: A Potential Tool for Managing Inflammatory Bowel Disease

The researchers discuss the potential benefits of antibiotics in IBD, particularly in managing active Crohn's disease and suppurative complications. They highlight promising results for rifaximin in treating Crohn's disease, but also acknowledge the need for further research to determine the optimal use of antibiotics in IBD.

Navigating the Complexities of IBD Treatment

This research underscores the complex nature of IBD and the need for a multifaceted approach to treatment. While antibiotics may play a role, they are not a cure-all. It is essential to consult with a healthcare professional to develop a personalized treatment plan that addresses the specific needs of each patient.

Dr. Camel's Conclusion

The role of antibiotics in IBD is a complex and evolving area of research. This study provides valuable insights into the potential benefits and limitations of antibiotic therapy. Just as a camel must adapt to the changing conditions of the desert, IBD treatment requires a flexible and personalized approach, considering the unique challenges faced by each patient.

Date :
  1. Date Completed 2017-01-17
  2. Date Revised 2022-03-30
Further Info :

Pubmed ID

26811648

DOI: Digital Object Identifier

PMC4716021

Related Literature

Article Analysis
・Side Effects of rifaximin
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.